Literature DB >> 17852145

Uterotropic effects of dietary equol administration in ovariectomized Sprague-Dawley rats.

D Rachoń1, T Vortherms, D Seidlová-Wuttke, A Menche, W Wuttke.   

Abstract

AIM: The aim of the present study was to evaluate the uterotropic effects of the administration of dietary equol, a metabolite of soy-derived daidzein or formononetin present in red clover, in an ovariectomized rat model of menopause.
METHOD: Two doses of racemic equol were used (50 mg/kg of chow and 400 mg/kg of chow) and the results were compared with two doses of estradiol-3 benzoate (E2B) (4.3 mg/kg of chow and 17.3 mg/kg of chow). After 3 months, animals were sacrificed and the uteri were removed, weighed and paraffin-embedded for morphometrical and immunohistochemical evaluation. The expression of selected uterine estrogen-responsive genes was also measured using real-time reverse transcription-polymerase chain reaction.
RESULTS: Compared to controls, uterine weights in animals treated with high-dose equol were significantly higher, presented histologic features of mild estrogenic stimulation and had greater epithelial height and thickness of the uterine stroma and myometrium. Staining for the presence of the proliferating cell nuclear antigen (PCNA) also showed a greater prevalence of the PCNA-positive cells in the uterine stroma in animals treated with high-dose equol. Conversely, the percentage of PCNA-positive cells in the uterine epithelium was lower compared to the controls. Dietary high-dose equol treatment also increased significantly levels of uterine insulin-like growth factor 1, progesterone receptor and complement protein 3 mRNA. Although statistically significant, all these effects were, however, lower in magnitude compared to the effects of low- and high-dose E2B treatment. Low-dose equol did not have any effects on the above-studied parameters.
CONCLUSION: Long-term high-dose dietary equol administration to ovariectomized rats exerts uterotropic effects at the cellular and molecular level which question the safety of uncontrolled and unlimited consumption of soy or red clover supplements by postmenopausal women with intact uteri.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852145     DOI: 10.1080/13697130701624757

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  7 in total

1.  Endogenous and exogenous equol are antiestrogenic in reproductive tissues of apolipoprotein e-null mice.

Authors:  Fitriya N Dewi; Charles E Wood; Johanna W Lampe; Meredith A J Hullar; Adrian A Franke; Deborah L Golden; Michael R Adams; J Mark Cline
Journal:  J Nutr       Date:  2012-08-29       Impact factor: 4.798

2.  Impact of perinatal exposure to equol enantiomers on reproductive development in rodents.

Authors:  Nadine M Brown; Stephanie L Lindley; David P Witte; Kenneth D R Setchell
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

3.  Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized rats.

Authors:  Leecole L Legette; Berdine R Martin; Mohammad Shahnazari; Wang-Hee Lee; William G Helferich; Junqi Qian; David J Waters; Alireza Arabshahi; Stephen Barnes; Jo Welch; David G Bostwick; Connie M Weaver
Journal:  J Nutr       Date:  2009-08-26       Impact factor: 4.798

4.  S-equol Exerts Estradiol-Like Anorectic Action with Minimal Stimulation of Estrogen Receptor-α in Ovariectomized Rats.

Authors:  Yuri Nishimura; Kaori Mabuchi; Azusa Takano; Yayoi Hara; Hiroko Negishi; Keiko Morimoto; Tomomi Ueno; Shigeto Uchiyama; Akira Takamata
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-19       Impact factor: 5.555

5.  Developmental and Reproductive Effects of SE5-OH: An Equol-Rich Soy-Based Ingredient.

Authors:  Ray A Matulka; Ikuo Matsuura; Tohru Uesugi; Tomomi Ueno; George Burdock
Journal:  J Toxicol       Date:  2008-12-15

6.  Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis.

Authors:  Ilona Kaczmarczyk-Sedlak; Weronika Wojnar; Maria Zych; Ewa Ozimina-Kamińska; Joanna Taranowicz; Agata Siwek
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-12       Impact factor: 2.629

Review 7.  Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.

Authors:  Dominik Rachoń
Journal:  Rev Endocr Metab Disord       Date:  2015-12       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.